125 related articles for article (PubMed ID: 2554521)
1. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
2. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
Shen L; Villoutreix BO; Dahlbäck B
Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
[TBL] [Abstract][Full Text] [Related]
5. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
Van Walderveen MC; Berry LR; Chan AK
J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes.
Laurell M; Carlson TH; Stenflo J
Thromb Haemost; 1988 Oct; 60(2):334-9. PubMed ID: 3217924
[TBL] [Abstract][Full Text] [Related]
7. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
Marlar RA; Kressin DC; Madden RM
Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
[TBL] [Abstract][Full Text] [Related]
8. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
11. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
[TBL] [Abstract][Full Text] [Related]
12. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
Heeb MJ; Griffin JH
J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
[TBL] [Abstract][Full Text] [Related]
13. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
15. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
Laurell M; Stenflo J
Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of plasma protein C inhibitor.
España F; Berrettini M; Griffin JH
Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
[TBL] [Abstract][Full Text] [Related]
17. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
Radtke KP; Stief TW; Heimburger N
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
[TBL] [Abstract][Full Text] [Related]
18. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
[TBL] [Abstract][Full Text] [Related]
19. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
Kazama Y; Koide T
Thromb Haemost; 1992 Jan; 67(1):50-5. PubMed ID: 1319617
[TBL] [Abstract][Full Text] [Related]
20. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
